SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
SEC Accession No. 0001493152-21-008441
Filing Date
2021-04-09
Accepted
2021-04-09 17:03:35
Documents
7

Document Format Files

Seq Description Document Type Size
1 forms-1a.htm S-1/A 129822
2 ex1-1.htm EX-1.1 304053
3 ex5-1.htm EX-5.1 32144
4 ex10-15.htm EX-10.15 181902
5 ex99-5.htm EX-99.5 16039
6 ex5-1_001.jpg GRAPHIC 4892
7 ex5-1_002.jpg GRAPHIC 3784
  Complete submission text file 0001493152-21-008441.txt   677410
Mailing Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010
Business Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010 (212) 994-8200
Protagenic Therapeutics, Inc.\new (Filer) CIK: 0001022899 (see all company filings)

IRS No.: 061390025 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1/A | Act: 33 | File No.: 333-253006 | Film No.: 21818463
SIC: 7389 Services-Business Services, NEC